Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-14 Sale | 2023-12-18 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 4,000 | $235.5 | $942,000 | 42,067 (Direct) | View |
| 2023-12-12 Sale | 2023-12-14 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,800 | $222.82 | $846,700 | 50,567 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 10,000 | $273.24 | $2,732,438 | 60,667 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-23 Option Award | 2024-01-25 5:50 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,557 | $0 | 10,093 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:45 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 550 | $243.92 | 5,117 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 4,000 | $87.92 | 42,067 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:30 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 4,000 | $0 | 42,067 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,800 | $87.92 | 50,567 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:30 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,800 | $0 | 50,567 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-02 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 10,000 | $87.92 | 60,667 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-02 4:30 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 10,000 | $0 | 60,667 (Direct) | View |
| 2023-01-16 Option Award | 2023-01-18 8:00 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 5,667 | $0 | 5,667 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-24 8:17 pm | N/A 2022-02-24 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 12,250 | $0 | 12,250 (Direct) | View |
| 2021-08-02 Option Award | 2021-08-04 9:46 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 35,000 | $0 | 35,000 (Direct) | View |